Evidence map›Paper›PMID 40133528›Full record

ArticleNature medicine2025

Transmission dynamics of the 2022 mpox epidemic in New York City.

Jonathan E Pekar, Yu Wang, Jade C Wang, Yucai Shao, Faten Taki, Lisa A Forgione, Helly Amin, Tyler Clabby, Kimberly Johnson, Lucia V Torian and 8 more

Abstract read
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Relationship dynamics and behavioral adaptations in the control of the 2022 mpox epidemic.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jonathan E PekarInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK. jpekar@ed.ac.uk.ORCID http://orcid.org/0000-0003-0977-2886
Yu WangDepartment of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA.
Jade C WangBioinformatics and Systems Biology Graduate Program, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-8855-0925
Yucai ShaoDepartment of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
Faten TakiNew York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and Sexually Transmitted Infections, Long Island City, NY, USA.
Lisa A ForgioneNew York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and Sexually Transmitted Infections, Long Island City, NY, USA.
Helly AminNew York City Department of Health and Mental Hygiene, Public Health Laboratory, New York, NY, USA.
Tyler ClabbyNew York City Department of Health and Mental Hygiene, Public Health Laboratory, New York, NY, USA.ORCID http://orcid.org/0009-0000-3887-4510
Kimberly JohnsonNew York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and Sexually Transmitted Infections, Long Island City, NY, USA.
Lucia V TorianNew York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and Sexually Transmitted Infections, Long Island City, NY, USA.
Sarah L BraunsteinNew York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and Sexually Transmitted Infections, Long Island City, NY, USA.
Preeti PathelaNew York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and Sexually Transmitted Infections, Long Island City, NY, USA.
Enoma OmoregieNew York City Department of Health and Mental Hygiene, Public Health Laboratory, New York, NY, USA.
Scott HughesNew York City Department of Health and Mental Hygiene, Public Health Laboratory, New York, NY, USA.ORCID http://orcid.org/0000-0001-8882-2946
Marc A SuchardDepartment of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9818-479X
Tetyana I VasylyevaDepartment of Population Health and Disease Prevention, Joe C. Wen School of Public Health, University of California Irvine, Irvine, CA, USA.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2826-5353
Joel O WertheimDepartment of Medicine, University of California San Diego, La Jolla, CA, USA. jwertheim@health.ucsd.edu.ORCID http://orcid.org/0000-0003-4882-5856

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Kristian Graugaard Andersen · 2018 to 2026
$32.0M
Automation and Evaluation of Real-Time Transmission Network-Based HIV Prevention Services in New York CityR01AI135992 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WERTHEIM, JOEL OKRENT · 2018 to 2022
$3.6M
Statistical Innovation to Integrate Sequences and Phenotypes for Scalable Phylodynamic InferenceR01AI153044 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Marc A. Suchard · 2021 to 2026
$2.4M
NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI135992NIAID NIH HHS R01 AI153044NIAID NIH HHS U19 AI135995U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC) PS21-2102U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI135992U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI135995U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI153044
6 · The paper itself

Abstract

The 2022 global mpox epidemic was caused by transmission of MPXV clade IIb, lineage B.1 through sexual contact networks, with New York City (NYC) experiencing the first and largest outbreak in the United States. By performing phylogeographic analysis of MPXV genomes sampled from 757 individuals in NYC between April 2022 and April 2023, and 3,287 MPXV genomes sampled around the world, we identify over 200 introductions of MPXV into NYC with at least 84 leading to onward transmission. These infections primarily occurred among men who have sex with men, transgender women and nonbinary individuals. Through a comparative analysis with HIV in NYC, we find that both MPXV and HIV genomic cluster sizes are best fit by scale-free distributions, and that people in MPXV clusters are more likely to have previously received an HIV diagnosis and be a member of a recently growing HIV transmission cluster. We model MPXV transmission through sexual contact networks and show that highly connected individuals would be disproportionately infected at the start of an epidemic, which would likely result in the exhaustion of the most densely connected parts of the network, and, therefore, explain the rapid expansion and decline of the NYC outbreak. By coupling the genomic epidemiology of MPXV and HIV with epidemic modeling, we demonstrate that the transmission dynamics of MPXV in NYC can be understood by general principles of sexually transmitted pathogens.

Indexed as

EpidemicsHIV InfectionsDisease OutbreaksFemaleHIV-1Homosexuality, MaleHumansMaleMpox, MonkeypoxNew York CityPhylogenyPhylogeographySexual Behavior

Identifiers

PMID40133528
PMCPMC12092259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.